Fundus autofluorescence before and after photodynamic therapy for chronic central serous chorioretinopathy

Ophthalmologica

Volumn 223, Issue 4, 2009, Pages 263-268

  Özmert, Emin ^a   Batioǧlu, Figen ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Central serous chorioretinopathy; Fundus autofluorescence; Optical coherence tomography; Photodynamic therapy

Indexed keywords

ADULT; ARTICLE; AUTOFLUORESCENCE IMAGING; CENTRAL SEROUS RETINOPATHY; CHRONIC DISEASE; CLINICAL ARTICLE; EYE FUNDUS; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; INDOCYANINE GREEN ANGIOGRAPHY; MALE; PHOTODYNAMIC THERAPY; PIGMENT EPITHELIUM; RETINA DETACHMENT; TREATMENT OUTCOME; VISUAL ACUITY;

ADULT; CHOROID DISEASES; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; FUNDUS OCULI; HUMANS; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; RETINA; RETINAL DISEASES; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME;

EID: 63349102663     PISSN: 00303755     EISSN: None     Source Type: Journal    
DOI: 10.1159/000210386     Document Type: Article

References (29)

1. Gass JDM: Pathogenesis of disciform detachment of the neuroepithelium. II. Idiopathic central serous chorioretinopathy. Am J Ophthalmol 1967;63:587-615.
2. Gass JDM: Stereoscopic Atlas of Macular Diseases: Diagnosis and Treatment, ed 4. St Louis, Mosby, 1997, vol 1, pp 52-70.
3. Gilbert CM, Owens SL, Smith PD, Fine SL: Long-term follow-up of central serous chorioretinopathy. Br J Ophthalmol 1984;68: 815-820.
4. Hussain D, Gass JD: Idiopathic central serous chorioretinopathy. Indian J Ophthalmol 1998;46:131-137.
5. Costa RA, Scapucin L, Moraes NS, et al: Indocyanine green-mediated photothrombosis as a new technique of treatment for persistent central serous chorioretinopathy. Curr Eye Res 2002;25:287-297.
6. Berger AR, Olk RJ, Burgess D: Central serous chorioretinopathy in patients over 50 years of age. Ophtha lmic Surg 1991;22:583-590.
7. Jalkh AE, Jabbour N, Avila MP, Trempe CL, Schepens CL: Retinal pigment epithelium decompensation. I. Clinical features and natural course. Ophthalmology 1984;91: 1544-1548 .
8. Jalkh AE, Jabbour N, Avila MP, Trempe CL, Schepens CL: Retinal pigment epithelium decompensation. II. Laser treatment. Ophthalmolog y 1984;91:1549-1553.
9. Yannuzzi LA, Slakter JS, Kaufman SR, Gupta K: Laser treatment of diffuse retinal pigment epitheliopathy. Eur J Ophthalmol 1992;2:103-114.
10. Piccolino FC, Eandi C, Ventre L, Longrais RCR, Grignolo FM: Photodynamic therapy for chronic central serous chorioretinopathy. Retina 2003;23:752-763.
11. Taban M, Boyer DS, Thomas EL, Taban M: Chronic central serous chorioretinopathy: photodynamic therapy. Am J Ophthalmol 2004;137:1073-1080.
12. Yannuzzi LA, Slakter JS, Gross NE, et al: Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study. Retina 2003;23:288-298.
13. Yoshioka H, Katsume Y: Experimental central serous chorioretinopathy. III. Ultrastructural findings. Jpn J Ophthalmol 1982;26:397-402.
14. Hall LS, Guyer DR, Yanuzzi LA: Central serous retinopathy; in Guyer DR, Yanuzzi LA, Chang S, Shields JA, Green WR (eds): Retina-Vitreus-Macula. Philadelphia, Saunders, 1999, vol 1, pp 206-216.
15. Kitagawa K, Nishida S, Ogura Y: In vivo quantitation of autofluorescence in human RPE. Ophthalmologica 1989;199:116-121.
16. Delori FC, Dorey K, Staurenghi G, Arend O, Goger DG, Weiter JJ: In vivo autofluorescence of the ocular fundus exhibits retinal pigment epithelial lipofuscin characteristics. Invest Ophthalmol Vis Sci 1995;36:718-729.
17. Von Rückmann A, Fizke FW, Bird AC: Distribution of fundus autofluorescence with scanning laser ophthalmoscope. Br J Ophthalmol 1995;119:543-562.
18. Von Rückmann A, Fizke FW, Bird AC: Fundus autofluorescence in age-related macular disease imaged with a laser scanning ophthalmoscope. Invest Ophthalmol Vis Sci 1997;38:478-486.
19. Von Rückmann A, Fizke FW, Fan J, Halfyard A, Bird AC: Abnormalities of fundus autofluorescence in central serous retinopathy. Am J Ophthalmol 2002;133:780-786.
20. Eandi CM, Ober M, Iranmanesh R, Peiretti E, Yannuzzi LA: Acute central serous chorioretinopathy and fundus autofluorescence. Retina 2005;25:989-993.
21. Framme C, Walter A, Gabler B, Roider J, Sachs G, Gabel VP: Fundus autof luorescence in acute and chronic recurrent central serous chorioretinopathy. Acta Ophthalmol Scand 2005;83:161-167.
22. Holz PG, Schuett F, Kopitz J, et al: Inhibition of lysosomal degradative functions in RPE cells by a retinoid of component of lipofuscin. Invest Ophthalmol Vis Sci 1999;40:737-743.
23. Framme C, Roider J: Immediate and longterm changes of fundus autofluorescence in continuous wave laser lesions of the retina. Ophthalmic Surg Lasers Imaging 2004;35: 131-138.
24. Feeney-Burns L, Hildebrand ES, Eldridge S: Ageing human RPE: morphometric analysis of macular, equatorial and peripheral cells. Invest Ophthalmol Vis Sci 1984;25:195-200.
25. Woodburn KW, Engelman CJ, Blumenkranz MS: Photodynamic therapy for choroidal neovascularization. Retina 2002;22:391-405.
26. Schotzer-Schrehardt U, Viestenz A, Naumann GOH, et al: Dose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes. Graefes Arch Clin Exp Ophthalmol 2002;240: 748-757.
27. Schimdt-Erfurth U, Michels S, Barbazetto I, Laqua H: Photodynamic effects on choroidal neovascularization and physiological choroid. Invest Ophthalmol Vis Sci 2002;43:830-841.
28. Husain D, Miller JW, Michand N, et al: Intravenous infusion of liposomal benzopor-phyrin derivative for photodynamic therapy of experimental choroidal neovascularization. Arch Ophthalmol 1996;114:978-985.
29. Haimovici R, Kramer M, Miller JW, et al: Localization of lipoprotein-derived benzoporphyrin in the rabbit eye. Curr Eye Res 1997;16:83-90.